Research is ongoing in a variety of cancers, including breast cancer, lung cancer, and pancreatic cancer. Clinical trials are examining the effectiveness of hydroxychloroquine in combination with standard therapies. Early results have been promising, showing enhanced treatment efficacy and improved patient outcomes.
